Qiagen is closer to completing its DKK683 million ($104 million) acquisition of Exiqon, a provider of RNA analysis solutions, but has decided to extend for a second time the offer period for Exiqon’s shares.
{iframe}https://www.genomeweb.com/business-news/qiagen-extends-offer-acquire-exiqon-second-time?utm_source=SilverpopMailing&utm_medium=email&utm_campaign=Daily%20News:%20Qiagen%20Extends%20Offer%20to%20Acquire%20Exiqon%20for%20Second%20Time%20-%2006/03/2016%2003:55:00%20PM{/iframe}